Jan 10 - Valeant to sell $2.1-billion in assets to pay debt Valeant Pharmaceuticals International Inc., the embattled Canadian drug maker, agreed to sell about $2.1-billion in assets to get cash to streamline its businesses and begin easing its debt burden.
L’Oreal SA will pay Valeant $1.3-billion for three skincare brands, the Paris-based company Tuesday said in a statement. Earlier in the day, Valeant said it would sell its Dendreon Pharmaceuticals unit to closely held Chinese conglomerate Sanpower Group Co. for about $820-million.
Link to article:
https://www.theglobeandmail.com/report-on-business/valeant-to-sell-21-billion-in-assets-to-pay-down-debt/article33561376/